Equine synovitis study highlights tradeoffs of ACS and triamcinolone

A new study in Animals compared intra-articular triamcinolone acetonide and autologous conditioned serum, or ACS, in six healthy adult horses using an IL-1β-induced synovitis model. The crossover study found a mixed picture: triamcinolone more consistently reduced visible swelling and joint effusion after the initial post-injection period, while ACS was associated with less lameness than triamcinolone at some later time points and appeared to blunt synovial fluid PGE2 increases and limit cartilage catabolism relative to triamcinolone. At the same time, ACS itself triggered synovial responses, including increased heat, swelling, effusion, and total nucleated cell count when given alone. (holocron.lib.auburn.edu)

Why it matters: For equine veterinarians, the paper adds nuance to a familiar treatment decision. Corticosteroids remain widely used because they are accessible and effective for symptom control, but prior work has raised concern about cartilage effects and, in some horses, metabolic consequences. ACS and related orthobiologics have drawn interest as steroid-sparing options, yet the broader evidence base is still limited by small studies and inconsistent controls. This study suggests ACS may offer biologic advantages in an acutely inflamed joint, but it also reinforces that orthobiologics can provoke their own short-term joint reaction and shouldn't be viewed as interchangeable with steroids. (holocron.lib.auburn.edu)

What to watch: The next step is whether larger clinical studies in horses with naturally occurring osteoarthritis confirm that ACS can improve outcomes without the tradeoffs seen with intra-articular steroids. (holocron.lib.auburn.edu)